BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 22270043)

  • 1. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
    Paul S
    Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation and ubiquitination in neurodegeneration.
    Riederer BM; Leuba G; Elhajj Z
    Exp Biol Med (Maywood); 2013 May; 238(5):519-24. PubMed ID: 23856903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
    Iacovelli L; Fulceri F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
    Exp Neurol; 2006 Sep; 201(1):24-31. PubMed ID: 16678160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.
    de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM
    Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
    Tai HC; Schuman EM
    Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the ubiquitin proteasome system in Alzheimer's disease.
    Riederer BM; Leuba G; Vernay A; Riederer IM
    Exp Biol Med (Maywood); 2011 Mar; 236(3):268-76. PubMed ID: 21383047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
    Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
    Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.
    Deger JM; Gerson JE; Kayed R
    Aging Cell; 2015 Oct; 14(5):715-24. PubMed ID: 26053162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].
    Shelkovnikova TA; Kulikova AA; Tsvetkov FO; Peters O; Bachurin SO; Bukhman VL; Ninkina NN
    Mol Biol (Mosk); 2012; 46(3):402-15. PubMed ID: 22888630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of autophagy in age-related neurodegeneration.
    McCray BA; Taylor JP
    Neurosignals; 2008; 16(1):75-84. PubMed ID: 18097162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
    Schmitt HP
    Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.